Chronic Resveratrol Treatment Reduces the Pro-angiogenic Effect of Human Fibroblast "Senescent-Associated Secretory Phenotype" on Endothelial Colony-Forming Cells: The Role of IL8.


Journal

The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837

Informations de publication

Date de publication:
23 04 2019
Historique:
received: 21 03 2018
pubmed: 8 8 2018
medline: 27 2 2020
entrez: 8 8 2018
Statut: ppublish

Résumé

Senescent cells are characterized by an increased secretion of inflammatory and growth factors, known as the "senescence-associated secretory phenotype" (SASP), producing a pro-tumoral and pro-angiogenic microenvironment. This work proposes chronic resveratrol treatment (5 µM for 5 weeks, termed R5) of senescent MRC5 fibroblasts as a mean to mimic and target the angiogenic trait of stromal fibroblast SASP. Senescent fibroblast conditioned medium (CM sen) was effective in enhancing the angiogenic properties of endothelial colony-forming cells (ECFCs), that is, invasive activity and capillary morphogenesis capability in vitro, that were significantly reduced when conditioned media were collected after resveratrol pretreatment (CM senR5). The attenuation of ECFC angiogenic phenotype induced by CM senR5 was accompanied by reduced protein levels of epidermal growth factor and urokinase plasminogen activator receptors (EGFR, uPAR), and by a related decreased activation of receptor-tyrosine-kinase signaling pathways. IL8 levels were found reduced in CM senR5 compared to CM sen, with the associated reduction of IL8-CXCR2 binding in ECFCs. IL8-subtraction mitigated the pro-angiogenic features of CM sen and the associated intracellular signaling in ECFCs, indicating a prominent role of IL8 in the pro-angiogenic effects of CM sen. IL8 modulation is an important mechanism underlying the antiangiogenic activity of resveratrol on MRC5 SASP.

Identifiants

pubmed: 30084946
pii: 5061967
doi: 10.1093/gerona/gly175
doi:

Substances chimiques

Antigens, Surface 0
Culture Media, Conditioned 0
Interleukin-8 0
Receptors, Urokinase Plasminogen Activator 0
Epidermal Growth Factor 62229-50-9
ErbB Receptors EC 2.7.10.1
Resveratrol Q369O8926L

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

625-633

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Beatrice Menicacci (B)

Department of Experimental and Clinical Biomedical Science "Mario Serio", Section of Experimental Pathology and Oncology, University of Florence.
Department of Medical Biotechnologies, University of Siena.

Francesca Margheri (F)

Department of Experimental and Clinical Biomedical Science "Mario Serio", Section of Experimental Pathology and Oncology, University of Florence.

Anna Laurenzana (A)

Department of Experimental and Clinical Biomedical Science "Mario Serio", Section of Experimental Pathology and Oncology, University of Florence.

Anastasia Chillà (A)

Department of Experimental and Clinical Biomedical Science "Mario Serio", Section of Experimental Pathology and Oncology, University of Florence.

Mario Del Rosso (M)

Department of Experimental and Clinical Biomedical Science "Mario Serio", Section of Experimental Pathology and Oncology, University of Florence.

Lisa Giovannelli (L)

Department NeuroFarBa, Section of Pharmacology and Toxicology, University of Florence, Italy.

Gabriella Fibbi (G)

Department of Experimental and Clinical Biomedical Science "Mario Serio", Section of Experimental Pathology and Oncology, University of Florence.

Alessandra Mocali (A)

Department of Experimental and Clinical Biomedical Science "Mario Serio", Section of Experimental Pathology and Oncology, University of Florence.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH